Werewolf Therapeutics, Inc. · NASDAQ:HOWL

Luke Evnin sold 205,911 Werewolf Therapeutics, Inc. shares (Form 4)

Traded Apr 27 to Apr 29, 2026 · Filed Apr 29, 2026

From Apr 27 to Apr 29, 2026, Luke Evnin (Director) sold 205,911 Werewolf Therapeutics, Inc. shares at an average US$0.75 for US$155K under a trading plan, leaving 1,953,949 shares. Filed Apr 29, 2026 (Form 4).

Sold
205,911 shares
Price
US$0.75 average (US$0.69 to US$0.85)
Value
US$155K
Holding after
1,953,949 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 27, 2026Common StockSale53,940US$0.852,105,920Indirect
Apr 28, 2026Common StockSale95,412US$0.732,010,508Indirect
Apr 29, 2026Common StockSale56,559US$0.691,953,949Indirect

Source

View original at SEC

Related